SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum

Autor: Preston, Frank G., Anson, Matthew, Riley, David R., Ibarburu, Gema H., Henney, Alexander, Lip, Gregory Y.H., Cuthbertson, Daniel J., Alam, Uazman *, Zhao, Sizheng S. *
Zdroj: In Clinical Therapeutics November 2024 46(11):835-840
Databáze: ScienceDirect
Externí odkaz: